
Study Period | 2019 - 2030 |
Market Size (2025) | USD 2.02 Billion |
Market Size (2030) | USD 2.85 Billion |
CAGR (2025 - 2030) | 7.09 % |
Fastest Growing Market | Asia Pacific |
Largest Market | North America |
Market Concentration | Medium |
Major Players![]() *Disclaimer: Major Players sorted in no particular order |
Protein Chip Market Analysis
The Protein Chip Market size is estimated at USD 2.02 billion in 2025, and is expected to reach USD 2.85 billion by 2030, at a CAGR of 7.09% during the forecast period (2025-2030).
Factors such as the rising burden of chronic diseases, increasing demand for personalized medicine, and advancements in proteomics research are poised to drive market growth during the forecast period.
Chronic diseases, including neurological disorders and cancer, are on the rise, driven by high body mass index, sedentary lifestyles, and poor dietary choices. This surge underscores the growing demand for effective diagnostics and therapeutics. For instance, according to an article published in the Indian Journal of Medical Research in March 2023, lung cancer was estimated to account for 103.37 thousands cases in 2022, ranking among the top five leading cancer sites for both males and females in India. Such a high burden of cancer cases heightens the demand for protein expression profiling. This technique measures thousands of proteins in cancer tissues, aiding in identifying overexpressed or under-expressed proteins across various cancer types.
Similarly, data from the National Health Service, United Kingdom, published in November 2023, highlighted a notable increase in dementia diagnoses. As of September 2023, approximately 475.57 thousand individuals received a dementia diagnosis, an increase of over 52 thousand from the previous year. This surge underscores the rising demand for protein chips, which play a pivotal role in identifying potential biomarkers for the early diagnosis and monitoring of dementia, thereby propelling market growth during the forecast period.
Additionally, protein microarrays are gaining traction in personalized medicine, allowing treatments and diagnoses to be customized according to individual patients' distinct protein profiles. Recognizing the importance of precision medicine, industry players and local authorities are promoting its adoption for more effective disease management, a move anticipated to drive market growth in the coming years.
For instance, in March 2023, the National University of Singapore (NUS) Medicine integrated Olink technology to fast-track precision medicine via next-generation proteomics. By establishing this core facility at NUS Medicine, Olink bolsters its foothold in the South Asia-Pacific region, making its cutting-edge proteomics technologies accessible to a broader population.
Furthermore, increased research efforts are analyzing the role of proteomics in drug discovery, driving the demand for protein chips in the market over the forecast period. For instance, a January 2024 article from the Royal Society of Chemistry in China highlighted that researchers found protein analysis pivotal for the high-throughput identification of new drug targets, suggesting a transformative potential for drug discovery. Such advantages of proteomics in drug development are poised to drive market growth during the study period.
Moreover, companies increasingly focus on strategic activities like acquisitions, collaborations, and product launches. These moves are anticipated to broaden the applications of protein microarrays, thereby propelling market growth. For instance, in March 2023, Spectrum Solutions acquired Microarrays, Inc., a producer of array-based products pivotal for biological research, including gene expression arrays and both reverse and forward phase protein arrays. This acquisition aims to bolster Spectrum's product and service offerings, streamlining its market entry strategies.
Therefore, the rising incidences of cancer and dementia, alongside the growing use of protein microarrays in personalized medicine and proactive company strategies, are expected to fuel the market growth. However, the high cost of instruments and the complexity of data analysis will likely impede the growth of the protein chip market over the forecast period.
Protein Chip Market Trends
Antibody Characterization Segment is Expected to Witness Significant Growth Over the Forecast Period
Antibody characterization is poised for substantial growth in the coming years. This surge is driven by various factors such as the rising prevalence of chronic diseases drives this surge, the growing demand for antibody-based therapeutics, increased funding in biomedical research, technological advancements in antibody development, and an increasing application of antibody-based assays in clinical diagnostics.
Furthermore, the rising focus of the companies to launch novel protein microarray technologies and platforms for antibody analysis is expected to fuel its adoption, hence anticipated to drive the segment growth over the forecast period. For instance, in October 2023, Sengenics Corporation LLC launched i-Ome Discovery, a cutting-edge protein microarray platform designed to analyze autoantibodies linked to disease diagnosis and treatment. Leveraging Sengenics' patented KREX technology, i-Ome Discovery showcased full-length, properly folded, and fully functional autoantigen proteins. This ensures highly sensitive, specific, and reproducible detection of autoantibodies.
Moreover, in September 2023, Yamaha Motors launched a new healthcare company, dubbed Tuning Fork Bio which uses profiling to test and analyze people's antibodies, aiding healthcare providers in disease prevention and tailored treatments. Using artificial intelligence, the company's technology uses data compared with previously compiled databases and healthy individuals to develop and select the correct therapeutic methods for a patient.
Therefore, owing to the rising research and development studies related to the use of antigen-protein chips in diagnosing and treating diseases coupled with new product launches and growing company activities, the studied segment is expected to grow over the forecast period.

North America is Expected to Hold Significant Market Share Over the Forecast Period
North America is expected to have a significant share of the market owing to factors such as the rising prevalence of cancer, neurological disorders, and cardiovascular diseases coupled with the growing demand for personalized medicine.
In addition, the rising research and development activities in proteomics, coupled with new product launches and strategic activities by key players, are set to fuel market growth, especially with the integration of advanced technologies.
For instance, as per the 2023 Alzheimer's Disease Facts and Figures report by the Alzheimer’s Association, approximately 6.7 million Americans aged 65 and older are living with Alzheimer's dementia in 2023, with projections suggesting this could rise to 13.8 million by 2060 without medical breakthroughs. This anticipated surge in Alzheimer's cases underscores the pressing need for early detection, which is likely to boost the adoption of protein biochips. These biochips can accurately identify Alzheimer's patients, further driving market expansion.
Furthermore, the new product launches by the key players for protein analysis are expected to fuel the availability of such products in the market, propelling market growth. For instance, in January 2024, Agilent Technologies launched the ProteoAnalyzer system, an innovative automated parallel capillary electrophoresis system designed for protein analysis. This cutting-edge automated parallel capillary electrophoresis system streamlines the analysis of complex protein mixtures, a pivotal step for sectors like pharmaceuticals, biotechnology, and academia.
Moreover, the acquisition strategy adopted by the key players to accelerate the development of next-generation proteomics for the discovery and development of novel drugs is further anticipated to drive market growth over the forecast period. For instance, in July 2024, Thermo Fisher Scientific Inc. acquired Olink Holding AB, a provider of next-generation proteomics solutions for discovery and development, at approximately USD 3.1 billion. With this acquisition, the company intends to utilize Olink’s proven and transformative solutions for proteomics with its leading mass spectrometry and life sciences offerings which enable scientists and researchers around the globe to meaningfully accelerate discovery and scientific breakthroughs.
Therefore, with the significant burdens of cancer, cardiovascular diseases, and Alzheimer's in the population, along with the rising adoption of protein chips, strategic acquisitions by industry leaders, and continuous product innovations, the North American market is set for robust growth in the coming years.

Protein Chip Industry Overview
The market for protein chips is fragmented, with a large number of players. The key players are adopting various strategies, such as collaborations, partnerships, acquisitions, and new product launches, to accelerate the production of protein chip technology and products and retain their market position. Some of the key players in the market include Agilent Technologies, Inc., PerkinElmer, Bio-Rad Laboratories, Thermo Fisher Scientific Inc., and Illumina, Inc., among others.
Protein Chip Market Leaders
-
Agilent Technologies, Inc.
-
PerkinElmer
-
Thermo Fisher Scientific Inc.
-
Illumina, Inc.
-
Bio-Rad Laboratories, Inc.
- *Disclaimer: Major Players sorted in no particular order

Protein Chip Market News
- February 2024: SPOC Proteomics, Inc. launched its customizable sensor-integrated proteome on chip (SPOC) biosensors for a limited beta test at SLAS2024, The innovative SPOC technology offers real-time, label-free biosensing capabilities, detecting up to 1000 fully folded proteins on a compact 1.5 cm2 SPR chip.
- February 2024: Alamar Biosciences, a company specializing in precision proteomics for early disease detection, secured USD 100 million in a Series C financing round. This funding will accelerate the commercialization of their advanced precision proteomics solutions.
Protein Chip Industry Segmentation
As per the scope of the report, protein chips, commonly known as protein microarrays, serve as a high-throughput method to monitor protein interactions and activities and to ascertain their functions on a large scale. Typically, these arrays are created by depositing molecular probes onto a solid support. These probes are meticulously designed to capture specific proteins at designated sites. Protein arrays find applications in five primary domains: diagnostics, proteomics, protein functional analysis, antibody characterization, and treatment development.
The protein chip market is segmented by type, application, end-user, and geography. By type, the market is segmented by analytical microarrays, functional protein microarrays, and reverse phase protein microarrays. By application, the market is segmented by Antibody Characterization, clinical diagnostics, and proteomics. By end user, the market is segmented by hospitals & clinics, diagnostic laboratories, academic & research institutes, and pharmaceutical & biotechnology companies. By geography, the market is divided into North America, Europe, Asia-Pacific, Middle East and Africa, and South America. The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD) for the above segments.
By Type | Analytical Microarrays | ||
Functional Protein Microarrays | |||
Reverse Phase Protein Microarrays | |||
By Application | Antibody Characterization | ||
Clinical Diagnostics | |||
Proteomics | |||
By End User | Hospitals & Clinics | ||
Diagnostic Laboratories | |||
Academic & Research Institutes | |||
Pharmaceutical & Biotechnology Companies | |||
Geography | North America | United States | |
Canada | |||
Mexico | |||
Europe | Germany | ||
United Kingdom | |||
France | |||
Italy | |||
Spain | |||
Rest of Europe | |||
Asia-Pacific | China | ||
Japan | |||
India | |||
Australia | |||
South Korea | |||
Rest of Asia-Pacific | |||
Middle East and Africa | GCC | ||
South Africa | |||
Rest of Middle East and Africa | |||
South America | Brazil | ||
Argentina | |||
Rest of South America |
Protein Chip Market Research FAQs
How big is the Protein Chip Market?
The Protein Chip Market size is expected to reach USD 2.02 billion in 2025 and grow at a CAGR of 7.09% to reach USD 2.85 billion by 2030.
What is the current Protein Chip Market size?
In 2025, the Protein Chip Market size is expected to reach USD 2.02 billion.
Who are the key players in Protein Chip Market?
Agilent Technologies, Inc., PerkinElmer, Thermo Fisher Scientific Inc., Illumina, Inc. and Bio-Rad Laboratories, Inc. are the major companies operating in the Protein Chip Market.
Which is the fastest growing region in Protein Chip Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).
Which region has the biggest share in Protein Chip Market?
In 2025, the North America accounts for the largest market share in Protein Chip Market.
What years does this Protein Chip Market cover, and what was the market size in 2024?
In 2024, the Protein Chip Market size was estimated at USD 1.88 billion. The report covers the Protein Chip Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Protein Chip Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Protein Chip Industry Report
Statistics for the 2025 Protein Chip market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Protein Chip analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.